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NEUROENGINEERING
Neurotrophins are a family of proteins widely used in nerve regen-
eration for their ability to promote neuronal survival and growth 
(Greene, 1978; Huang and Reichardt, 2001). By incorporating neu-
rotrophins (e.g., nerve growth factor, NGF) into electrode coatings 
for controlled release to surrounding tissue, target neurons can be 
stimulated to survive and extend neurites toward electrode sites. This 
should reduce the separation distance between target neurons and 
electrodes. Unfortunately, the extremely short in vivo half-lives of 
neurotrophins make their sustained release challenging (Maysinger 
et al., 1996; Kishino et al., 2001). Previously, we demonstrated the 
potential of neurotrophin-eluting poly(ethylene glycol)-poly(lactic 
acid) (PEGPLA) hydrogels as coatings for planar microelectrode 
arrays (MEAs; Winter et al., 2007). Photo-polymerized, biodegrad-
able, PEG-based hydrogels were selected for their biocompatibility 
(Yowell and Blackwell, 2002; Eugene, 2004), ability to gel in situ 
(Anseth et al., 2002; Jain et al., 2006), and facile tailoring of release 
characteristics by changing polymer chain length, degradable repeat 
ratio, and cross-linking density (Sawhney et al., 1993). We showed 
that PEGPLA hydrogel coatings persisted on electrode surfaces for 
∼7 days in PBS immersion bath and ∼11 days under an agarose gel, 
and released bioactive NGF for at least 9 days (Winter et al., 2007). 
Although these results were promising in terms of reducing acute 
immune response caused by the trauma of electrode implantation 
(∼1.5–3 weeks post-implantation; Turner et al., 1999); coatings 
capable of longer electrode adhesion and neurotrophin elution are 
required to address the chronic immune response, which is believed 
to occur for at least 2 months post-implantation (Turner et al., 1999).
IntroductIon
Neural prostheses have been explored for over two decades for their 
potential to restore lost function in the central nervous system (CNS; 
Grill et al., 2001; Loewenstein et al., 2004; Schwartz, 2004; Schwartz 
et al., 2006). However, clinical applications of these devices have been 
limited by the long-term instability of the CNS tissue–device inter-
face (Butson and McIntyre, 2005; Polikov et al., 2005). There are 
two primary factors that compromise electrode efficiency: (1) local 
tissue anatomy, which frequently prevents proximal device implanta-
tion and results in a significant separation of electrodes from target 
neurons (Lawrence et al., 2003; Loewenstein et al., 2004) and (2) the 
formation of an electrically insulating glial sheath composed of com-
pact activated astrocytes and microglia around the device as a result 
of cellular and tissue responses to the sustained presence of the device 
(Heiduschka and Thanos, 1998; Turner et al., 1999; Frampton et al., 
2010). These limitations ultimately lead to an increase in electrode 
impedance, which in turn affects device performance. Thus, to reduce 
the reactive response to implanted devices, considerable efforts have 
been made to improve the biocompatibility of neural prostheses, 
including modifications of the electrode material, electrode shape, 
and implantation techniques (Lawrence et al., 2003; Szarowski et al., 
2003; George et al., 2005), application of drugs to minimize reactive 
gliosis (Retterer et al., 2004; Winter et al., 2007; Jhaveri et al., 2009), 
and application of electrode coatings such as hydrogels (Winter et al., 
2007; Jun et al., 2008; Jhaveri et al., 2009), layer-by-layer films (He and 
Bellamkonda, 2005; He et al., 2006; Wu et al., 2007), and conducting 
polymers (Cui et al., 2001, 2003; Abidian and Martin, 2009).
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doi: 10.3389/fneng.2011.00002Morphology of PCL EFMs was characterized by scanning electron 
microscopy (SEM, Quanta 200, FEI). The average fiber diameter 
was 0.56 ± 0.084 mm (mean ± SD), and the range of fiber diam-
eter distribution was approximately 0.24–8.5 mm. Circular discs 
(∼1.5 mm dia.) were then cut from EFMs using dermal punches 
(Acuderm) for composite formation.
Poly(ethylene glycol)-poly(e-caprolactone) hydrogel–PCL EFM 
composites were created via photo-polymerization, following the 
method of Hubbell and colleagues (Sawhney et al., 1993). Precursor 
solution was prepared by adding initiators (Irgacure 2959, 0.1 wt%, 
Ciba, Tarrytown, NY, USA, and 1-vinyl-2-pyrrolidone, 0.5 wt%) 
into a solution of 22 wt% diacryl-PEGPCL polymer in Dulbecco’s 
phosphate buffered saline (D-PBS). 2 mL of precursor solution 
was placed on the desired substrate (i.e., Teflon™ for Eluted NGF 
measurement exp., electrode arrays for electrode coating adhesion, 
biocompatibility, and eluted NGF bioactivity tests), and exposed to 
UV illumination (100 W, 365 nm wavelength, Blak-Ray, B-100-AP, 
UVP) for 2 min to form PEGPCL hydrogel boluses. MEAs for coat-
ing adhesion were generously provided by Dr. Stuart Cogan (EIC 
Laboratories, Norwood, MA, USA), as shown in Figure 1. The 
arrays are composed of 15 (3 × 5), 400 μm circular, gold elec-
trodes covered by a sputtered 300 nm film of iridium oxide (SIROF) 
and a 50-nm titanium film between the electrode sites and SIROF, 
fabricated on a ∼10 mm thick polyimide substrate (Klein et al., 
1989). For composites formed on Teflon™ (shown in Figure 2A), 
PCL mats (D = 1.5 mm) were placed on Teflon™, followed by the 
deposition of 2 mL PEGPCL precursor solution on top of each mat, 
and exposed to UV illumination for 90 s. A second PCL mat was 
then placed on top of each bolus, and exposed to UV illumination 
for an additional 45 s. For composite electrode coating formation 
(shown in Figure 2B), 2 mL of PEGPCL precursor solution was 
dispensed over the distal end of a 3 × 5 electrode array, exposed 
to UV illumination for 90 s, followed by addition of a PCL mat 
(D = 1.5 mm) to the top of the bolus and continuing UV exposure 
for another 45 s.
characterIzatIon of composIte electrode coatIng adhesIon
Poly(ethylene  glycol)-poly(e-caprolactone)  hydrogel–PCL  EFM 
composites were deposited as electrode array coatings through UV 
illumination as described above. The coated electrode array was 
then inserted into an agarose gel (1% wt/v in D-PBS) and removed 
immediately. The integrity of coating was visually evaluated by 
Here, we present hydrogel–electrospun fiber mat (EFM) com-
posite electrode coatings, which adhered to electrode surfaces for 
over 9 months and eluted neurotrophins for at least 25 days. Since 
the duration of drug release and coating adhesion on electrodes 
can be increased by reducing polymer degradation rate (Sawhney 
et al., 1993; West and Hubbell, 1995), poly(ethylene glycol)-poly(e-
caprolactone) (PEGPCL) hydrogels were used in the composite 
coating instead of comparative molecular weight PEGPLA because 
of their slower degradation rate (Gadzinowski et al., 2000; Sun 
et al., 2003). EFMs have been extensively studied as tissue engi-
neering constructs for their potential to topographically mimic 
the extracellular matrix (ECM), which is important in controlling 
cell adhesion, cell morphology, and tissue architecture (Matthews 
et al., 2002; Luu et al., 2003; Boudriot et al., 2006). Also, EFMs with 
high porosity and surface area are attractive candidates in control-
led drug delivery (Kim et al., 2004) and are capable of maintaining 
the bioactivity of agents incorporated into fibers by electrospinning 
(Chew et al., 2005). Poly(e-caprolactone) (PCL) hydrophobic EFMs 
were used to construct hydrogel–EFM composite coatings because 
of their excellent biocompatibility and low biodegradation rate 
(Huatan et al., 1995). These novel hydrogel–EFM composites com-
bine the appealing features of both hydrogel and EFM systems, and 
hold great potential to improve the biocompatibility of implanted 
devices, thereby enhancing chronic electrode performance.
materIals and methods
pegpcl hydrogel–pcl efm composIte formatIon
All chemicals were used as received from Sigma-Aldrich, Inc., 
unless otherwise stated. Acryl-PEGPCL copolymers were synthe-
sized using a modification of the procedure (Rao et al., 2011) of 
Hubell and colleagues (Sawhney et al., 1993). Briefly, ring-  opening 
polymerization of e-caprolactone on the terminal hydroxyl of 
poly(ethylene glycol) (PEG; Mw: 950–1,050) was initiated by stan-
nous octanoate [Tin(II)2-ethylhexanoate], and completed after 
24 h at 130°C under an argon atmosphere. Acryloyl chloride in 
anhydrous dichloromethane (4 M excess) was added to a solution 
of purified PEGPCL intermediate and triethylamine (TEA) in anhy-
drous dichloromethane at a rate of ∼0.20 mL/min in an ∼ −30°C 
dry ice-acetone bath over 8 h. A thermocouple probe was used 
to monitor the bath temperature, which was controlled within a 
range of ±5°C. Acrylation was completed after continuous stir-
ring for 60 h. Byproduct TEA–HCl salt was removed by alternate 
repeated solvent evaporation and Buchner funnel filtration. After 
a series of purification steps described in (Rao et al., 2011), the col-
lected diacryl-PEGPCL copolymers were characterized by Fourier 
transform infrared spectroscopy (Nicolet 6700 FT-IR spectrometer, 
Thermo Scientific) and nuclear magnetic resonance spectroscopy 
(1H NMR Bruker DPX400). The 1H NMR and FT-IR spectra con-
firmed successful synthesis of diacryl-PEGPCL copolymer with a 
yield of 85.2%.
Poly(e-caprolactone)  mats  were  fabricated  by  electrospin-
ning. A 12-wt% solution of PCL (Mw: 65,000) in dichlorometh-
ane (Mallinckrodt Chemicals) was dispensed at a flow rate of 
3 mL/h, electrospun under a voltage of +30 kV, and deposited 
onto an aluminum foil target at a 20-cm tip-to-substrate distance 
(Gaumer et al., 2009). PCL mats were dried in a vacuum oven 
overnight (Nam et al., 2008) to remove residual dichloromethane. 
Figure 1 | Optical micrograph of the distal tip of the MeA array.
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Han et al.  Hydrogel–EFM compositesa Versamax UV-visible micro-plate reader with measurements 
performed in triplicate. Pooled data from each repetition was 
analyzed using one way analysis of variance (ANOVA; a = 0.01). 
Pair-wise comparisons were performed using the Holm–Sidak 
method (a = 0.05).
measurement of eluted ngf usIng elIsa
For NGF elution experiments, sterile PEGPCL precursor solu-
tion was added to lyophilized NGF (2.5 S, Promega, Madison, WI, 
USA) at a concentration of 1 mg/mL. Hydrogel–EFM composites 
(N = 3) with 2 mL NGF-containing hydrogel phase were created 
on Teflon™ as described in Section “PEGPCL Hydrogel–PCL EFM 
Composite Formation,” and placed on the upper surface of 0.4 mm 
membrane transwell inserts (Corning; Figure 2F). The insert was 
then placed in a 24-well tissue-culture plate (BD Biosciences) filled 
with 0.5 mL D-PBS placed in a 37°C, 5% CO2 incubator. To deter-
mine the amount of eluted NGF, 450 mL samples (N = 3) were 
collected at each time point (up to 25 days) and measured using 
the NGF EMax ELISA assay (Promega), following the manufacturer’s 
instructions for each sample. Fresh D-PBS (450 mL) was then used 
to replace the sample collected.
characterIzatIon of eluted ngf BIoactIvIty through pc12 cell 
neurIte extensIon
To evaluate bioactivity of eluted NGF, PC12 cells were used 
because of their ability to exhibit a neuronal phenotype including 
neurite extensions upon exposure to NGF, and retract neurites 
after NGF is withdrawn from the culture media. In the absence 
of NGF, PC12 cells maintain a rounded morphology with few 
neurite extensions. Cells were cultured at 1 × 104 cells/cm2 in 
24-well plates overnight. Electrode arrays coated with composites 
containing 5 wt% BSA or 1 mg NGF/mL in the hydrogel phase 
were attached to the side walls of wells (one electrode array/
well, triplicate for each sample; Note that cells do not contact 
phase contrast microscopy at 10× and 20× magnification. Long-
term composite coating adhesion (up to 9 months in D-PBS solu-
tion; N = 2 coated electrodes) was assessed by reflected differential 
interference contrast (Khademhosseini et al., 2004) optical micro-
scopy (Olympus BX41) and SEM (Quanta 200, FEI). Additionally, 
coated electrode arrays were placed under an agarose gel phantom 
(1% wt/v in D-PBS), which mimics the tissue that would constrain 
composite coatings under in vivo conditions. All images were con-
verted to grayscale using Adobe Photoshop (Version 10.0).
BIocompatIBIlIty of composIte electrode coatIngs
Before utilization in cell culture and NGF elution experiments, 
PEGPCL precursor solution was sterile-filtered through a 0.22 mm 
syringe filter with a 0.8 mm pre-filter (Millipore). Biocompatibility 
of composite electrode coatings was evaluated by culturing PC12 
cells (ATCC, CRL-1721, Manassas, VA, USA) at 1 × 104 cells/
cm2 in collagen-coated 24-well tissue-culture plates. Cells were 
incubated at 37°C, 5% CO2 overnight in 0.5 mL standard culture 
medium [Ham’s F12K Medium with 2 mM l-glutamine, 1.5 g/L 
sodium bicarbonate, 2.5% fetal bovine serum, 15% horse serum 
(all from Sigma-Aldrich), and 1% penicillin–streptomycin (Gibco, 
Carlsbad, CA, USA)]. Three different samples were evaluated in 
addition to a control sample (PC12 cells in culture wells). Sample 
C: Hydrogel–EFM composites (N = 3) of 2 mL hydrogel phase were 
created on Teflon™ and placed in a transwell insert (Figure 2C). 
Sample EC: a composite-coated electrode array was attached to 
the side wall of a well using adhesive carbon tape to avoid direct 
contact with PC12 cells at the bottom of the well (Figure 2D). 
Sample ECB: an electrode array coated by composite containing 
5 wt% bovine serum albumin (BSA, model drug) in the hydrogel 
phase was attached to the side wall of a well (Figure 2E). Cells 
were cultured in the presence of samples (N = 3 for each sample) 
for 2 weeks and then analyzed by the MTT cell viability assay fol-
lowing the manufacturer’s instructions. Data was collected using 
Figure 2 | Schematics of biocompatibility, NgF elution, and bioactivity tests. (A) hydrogel–EFM composite material. Gray = EFM, Yellow = Hydrogel; (B) 
composite coating on a MEA; (C) sample C (hydrogel–EFM composite); (D) sample EC (electrode with composite coating); (e) sample ECB (electrode with 
BSA-eluting composite coating); (F) NGF elution; (g) NGF bioactivity test.
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in Figure 3F has broken into small pieces covering individual 
electrode sites. Although degradation of the PEGPCL hydrogel 
component is evidently advancing in Figures 3D–F as seen by the 
receding edge of hydrogels, the presence of PCL EFMs reduces 
degradation of the hydrogel component by physically constrain-
ing hydrogels to electrode surfaces and reducing diffusion to the 
hydrogel surface. Additionally, some wrinkling of the EFM is 
evident in Figure 3F, likely driven by shrinkage of the hydrogel 
layer beneath it. Composite coatings demonstrated adhesion for 
at least 1 month in a tissue phantom test, in which a coated 
electrode array was placed under an agarose gel mimicking the 
effect of tissue (Figure 3G).
We also investigated the potential of coatings to withstand 
implantation into the brain. Each of the three composite electrode 
coatings was inserted into a 1% wt/v agarose gel (brain tissue 
has similar mechanical properties to softer 0.6% wt/v agarose 
gels; Chen et al., 2004). No delamination was observed for the 
coatings, demonstrating their potential to withstand the physical 
stresses associated with in vivo implantation (Figures 3H,I). These 
results suggest that the constraint created by PCL EFMs increases 
the persistence of the composite coating on the electrode surface 
and provide a first examination of the potential for clinical appli-
cation. However, since the arachnoidea, which is substantially 
tougher than 1% wt/v agarose gel, provides the first barrier in 
real brain; more tests (i.e., in vivo composite-coated electrode 
implantation studies) are required to validate coating resistance 
to implantation forces.
the composite coatings directly; Figure 2G). Cells were cultured 
for 2 weeks with medium exchanged every 2–3 days. Samples 
were compared to two controls, a positive control (N = 3) which 
received 50 ng/mL NGF added directly to the medium and a nega-
tive control (N = 3) which received no NGF. Neurite extension 
was assessed using phase contrast microscopy (Olympus IX71) at 
10× and 20× magnifications at day 7 and day 14 for all samples. 
Five pictures were randomly taken for each well. Neurite length 
(from the tip of each neurite branch to the soma) was measured 
using Image J software. Kruskal–Wallis one way ANOVA by ranks 
(a = 0.01, for non-parametric data) was applied to analyze pooled 
data from each repetition, whereas the Tukey test (a = 0.05) was 
performed for pair-wise comparisons.
results
characterIzatIon of composIte coatIng electrode adhesIon
Poly(ethylene  glycol)-poly(e-caprolactone)  hydrogels  and 
PEGPCL hydrogel–PCL EFM composites adhere to electrode 
arrays over the short-term optical micrographs (Figures 3A,B) 
and  SEM  (Figure  3C).  The  interaction  of  PCL  EFMs  with 
PEGPCL hydrogels can be seen by the roughness of the coating 
surface near the PCL EFM in Figure 3C, which probably resulted 
from the non-uniform shrinkage of the hydrogel as it was con-
strained by the EFM during dehydration. Coatings demonstrate 
both short and long-term adhesion on electrode surfaces in the 
presence of PBS (Figures 3D,E, 45 days and Figure 3F, 9 months). 
In Figures 3D,E, irregular margin outside the original hydro-
gel–EFM composite interface indicates the spread of degraded 
Figure 3 | Micrographs of PegPCL hydrogel–PCL eFM adhesion to 
electrode array surfaces. (A) Optical micrographs of the distal tip of an MEA 
array coated with PEGPCL hydrogel and (B) coated with PEGPCL hydrogel–PCL 
EFM composite at day 0. (C) SEM micrograph of the distal tip of an MEA coated 
with PEGPCL hydrogel–PCL EFM composite at day 0. (D,e) Optical micrographs 
of composite coating after soaking in PBS buffer for 45 days. (F) SEM 
micrograph of composite coating after soaking in PBS solution for 9 months. (g) 
Optical micrograph of composite coating at day 32 under an agarose tissue 
phantom. (H,i) Optical micrographs of composite + electrode array after 
insertion into and removal from an agarose tissue phantom. [Black arrows 
indicate the edge of the PEGPCL hydrogel; white arrows indicate the edge of 
PCL EFMs. Scale bar: 1 mm for (A–D,F,H); 500 mm for (e,g,i)].
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neurIte extensIon
The quality of NGF eluted from hydrogel–EFM composite elec-
trode coatings was evaluated using PC12 cell neurite extension. 
Composite electrode coatings delivered the targeted amount of 
bioactive NGF for over 2 weeks. Neurite extension of PC12 cells 
exposed to samples was characterized at day 7 and 14. At day 14, 
neurite extension was still evident (Figure 6A, NGF positive control 
and Figure 6B, coating), indicating that sufficient, bioactive NGF 
was released from composite electrode coatings to elicit a neuronal 
phenotype. The neurite number and length were similar to that of 
a positive control (which received 50 ng/mL NGF every other day 
for 14 days). Also, PC12 cells exposed to a negative control (no 
NGF) and a sham (BSA-releasing coatings) displayed rounded, 
undifferentiated morphologies at day 14 (Figures 6C,D), consistent 
with the expected morphology of PC12 cells not exposed to NGF.
For PEGPCL hydrogel–PCL EFM composite electrode coat-
ings, neurite length distributions at day 7 and day 14 were sta-
tistically insignificant (p > 0.05) from NGF positive control 
samples (Figures 7A,B), and statistically significant (p < 0.05) 
from negative control and sham (BSA-releasing coatings) sam-
ples (data not shown). These results were consistent with the 
observations in Figure 5. Also, for both composite electrode 
coatings and NGF+ control samples, neurite length distribu-
tions at day 14 were statistically different (p < 0.05) from those 
at day 7 (Figure 8), which reflected the sustained release of 
NGF from electrode coatings for over 14 days at a concentration 
sufficient to induce neurite extension. It should be noted that 
cells continued to extend neurites beyond the 14 day period 
investigated, but neurite length measurements beyond 14 days 
became difficult as a result of neurite branching and network 
BIocompatIBIlIty of composIte electrode coatIng
Poly(ethylene  glycol)-poly(e-caprolactone)  hydrogel–PCL  EFM 
composite electrode coatings did not demonstrate evident toxicity 
in a PC12 cell culture model. An MTT assay (Figure 4) indicated 
that negative control samples (PC12 cells cultured without expo-
sure to composites or composite electrode coatings) demonstrate 
no significant difference in cell number compared with samples 
exposed to composites (C), composite electrode coatings (EC), 
and composite electrode coatings releasing BSA (ECB; p = 0.81, 
N = 3, average of three replicates). Also, in phase contrast optical 
micrographs, cells responded to C, EC, and ECB by maintaining 
their undifferentiated, rounded morphology (data not shown). No 
qualitative morphology change was observed in all samples.
measurement of eluted ngf
The NGF Emax ELISA assay was used to determine the quantity of 
NGF eluted from PEGPCL hydrogels and PEGPCL hydrogel–PCL 
EFM composites. NGF was released from all samples over a period 
of 25 days (Figure 5). The concentration of NGF released from 
composite materials was higher than that of PEGPCL hydrogels at 
each time point, despite equal initial NGF loading. After 25 days 
exposure,  composite  materials  showed  significantly  extended 
release of NGF vs. PEGPCL hydrogel controls, which may result 
from the diffusion barrier provided by the EFM layers. Also, it is 
possible that the fabrication method used for composite materi-
als might better preserve NGF conformation than that used for 
PEGPCL hydrogels.
Figure 4 | Normalized absorbance from an MTT cell viability test. (The 
asterisk indicates no significant difference; p < 0.05).
Figure 5 | Concentration of eluted NgF as measured by eLiSA.
Figure 6 | representative phase contrast optical micrographs of PC12 
cells after 14 days cell culture. (A) Positive control receiving 50 ng/mL NGF 
in the media. (B) NGF-eluting composite coating as shown in Figure 2g. (C) 
Negative control receiving 0 ng/mL NGF . (D) Sham, BSA-releasing composite 
coating.
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reducing hydrogel degradation and improving coating adhesion 
duration. It is thus possible that adhesion duration of PEGPCL 
hydrogel–PCL EFM composite electrode coatings could be con-
trolled  by  applying  EFMs  of  different  shapes  and  sizes. Apart 
from adhesion, composite coatings were also capable of resisting 
implantation forces, as evidenced by insertion and removal tests in 
tissue phantoms (Figure 3I). These results are similar to those for 
PEGPCL hydrogel coatings observed previously (Rao et al., 2011). 
Thus composite coatings were able to withstand compression or 
shearing forces encountered during implantation. An interesting 
possibility is that the stability imparted by EFMs to the coatings 
may provide additional resistance to device movement associated 
with use, a target for future research.
To reduce device-related tissue damage, it is crucial to minimize 
the total size of neural prostheses, including coatings. The thick-
ness of hydrogel–EFM composites is easily controlled. By chang-
ing the weight percentage of polymer solution and the volume of 
the hydrogel bolus, we can modify the thickness of the PEGPCL 
hydrogel layer. The application of PCL EFMs on top of the hydro-
gel layer can improve the uniformity of the hydrogel coating, and 
the thicknesses of PCL EFMs can be easily modified by changing 
electrospinning fabrication parameters, i.e., polymer solution flow 
rate, deposition time, and tip-to-substrate distance.
Although electrochemical properties of composite electrode 
coatings were not characterized through cyclic voltammetry (CV), 
electrochemical impedance spectroscopy (EIS), and potential tran-
sient measurements, the results of previous electrochemical charac-
terization (Winter et al., 2007) showed very little effect of PEGPLA 
hydrogel coatings on the charge-injection properties of coated elec-
trodes, and no significant difference of the maximum electrochemi-
cal potential excursions and access voltage between coated and 
uncoated electrodes. Since PEGPCL hydrogels have similar physical 
and electrochemical properties to PEGPLA hydrogels, we believe 
it is very unlikely that a significant difference in electrochemical 
properties would be observed. Also, the effect of the coating on the 
electrode electrical properties would be mitigated by continued 
polymer degradation. Furthermore, to fully expose the electrode 
sites to surrounding tissue without any compromise of their elec-
trical properties, patterning techniques such as photolithography 
(Whitesides et al., 2001) or microfluidic channels (Khademhosseini 
et al., 2004) can be applied to control the spatial properties of the 
formation in both NGF+ control and electrode coating samples. 
Qualitatively, neurite extension of composite electrode coating 
samples remained visibly similar to NGF+ control samples and 
distinct from that of negative control and sham samples beyond 
14 days of cell culture.
dIscussIon
We have preliminarily demonstrated the potential of PEGPCL 
hydrogel–PCL EFM composites as electrode coatings to improve 
the biocompatibility of implanted devices. However, additional, 
in vivo composite coating studies are needed to confirm these results. 
Compared to the PEGPCL (Rao et al., 2011) and PEGPLA (Winter 
et al., 2007) hydrogel coatings investigated previously, which adhere 
to the electrode array surface for at least 28 and 10 days, respec-
tively, PEGPCL hydrogel–PCL EFM composite coatings displayed 
significantly longer electrode adhesion [over 9 months in PBS bath 
immersion tests (Figure 3F) and over 1 month in tissue phantom 
tests (Figure 3G)]. We also observed that coating regions not cov-
ered by EFMs (i.e., PEGPCL hydrogel only) degraded much more 
rapidly than regions covered by PCL EFMs (Figures 3E,F). These 
results suggest that PCL EFMs physically constrain the hydrogel 
Figure 7 | Histograms of neurite length after culture for (A) 7 days and 
(B) 14 days. Black: NGF positive control; gray: NGF-eluting composite 
electrode coatings.
Figure 8 | Percent of neurites possessing length < L at day 7 and 14.
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